Rapid detection of SM/EMB/LVFX/AMK/CPM resistance by DNA microarray for clinical isolates from spinal tuberculosis

程鹏; 张泽华; 李力韬; 张冠斌; 郭永; 罗飞; 周强; 代飞; 何清义; 许建中

您当前的位置：

首页 >

文章列表页 >

Rapid detection of SM/EMB/LVFX/AMK/CPM resistance by DNA microarray for clinical isolates from spinal tuberculosis

更新时间：2026-01-09

- Rapid detection of SM/EMB/LVFX/AMK/CPM resistance by DNA microarray for clinical isolates from spinal tuberculosis
- Journal of Army Medical University Vol. 36, Issue 13, Pages: 1345-1349(2014)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC： R372;R446.7;R529.2
- Published：2014
- 稿件说明：
移动端阅览
程鹏,张泽华,李力韬,张冠斌,郭永,罗飞,周强,代飞,何清义,许建中.基因芯片法快速检测脊柱结核临床分离株SM、EMB、LVFX、AMK、CPM耐药[J].陆军军医大学学报(原第三军医大学学报),2014,36(13):1345-1349.

　Cheng Peng,Zhang Zehua,Li Litao,Zhang Guanbin,Guo Yong,Luo Fei,Zhou Qiang,Dai Fei,He Qingyi,Xu Jianzhong.Rapid detection of SM/EMB/LVFX/AMK/CPM resistance by DNA microarray for clinical isolates from spinal tuberculosis[J].J Amry Med Univ (J Third Mil Med Univ),2014,36(13):1345-1349.
程鹏,张泽华,李力韬,张冠斌,郭永,罗飞,周强,代飞,何清义,许建中.基因芯片法快速检测脊柱结核临床分离株SM、EMB、LVFX、AMK、CPM耐药[J].陆军军医大学学报(原第三军医大学学报),2014,36(13):1345-1349. DOI：

　Cheng Peng,Zhang Zehua,Li Litao,Zhang Guanbin,Guo Yong,Luo Fei,Zhou Qiang,Dai Fei,He Qingyi,Xu Jianzhong.Rapid detection of SM/EMB/LVFX/AMK/CPM resistance by DNA microarray for clinical isolates from spinal tuberculosis[J].J Amry Med Univ (J Third Mil Med Univ),2014,36(13):1345-1349. DOI：

摘要

目的制备一种用于检测链霉素（streptomycin

SM）、乙胺丁醇（ethambutol

EMB）、左氧氟沙星(levofloxacin

LVFX)、阿米卡星(amikacin

AMK)、卷曲霉素（capreomycin

CMP）耐药基因的新型微阵列芯片，测试其快速检测脊柱结核临床分离株耐药的效果。方法根据SM、EMB、LVFX、AMK、CPM 5种药物的常见耐药基因及突变位点（rpsL、rrs、embB、rrs及gyrA），制备DNA微阵列芯片，脊柱结核临床分离株耐药菌株111株及敏感菌株26株，均具备完整的临床信息及药敏结果，依次进行灭活、核酸提取、PCR扩增、芯片杂交、洗涤与扫描判读，与表型药敏结果对照，计算敏感度、特异度及95%CI。结果检测时间18～23（20.1±1.2）h。与表型药敏结果对照，基因芯片检测SM、EMB、LVFX、AMK、CPM耐药的敏感度分别为90.36%、61.90%、94.59%、66.00%、65.52%，其对应的特异度分别为70.37%、58.11%、58.00%、91.95%、80.56%；在26株全敏感菌株中，结果均显示为野生型，对5种抗结核药物耐药检测的特异度均为100%。结论基因芯片法检测结核耐药耗时短，一线、二线耐药检测的敏感度、特异度令人满意，生物安全性高，能够满足临床耐多药结核快速诊断需要。

Abstract

Objective To detect the feasibility and efficiency of newly self-designed DNA microarray for rapid detection of resistance to streptomycin (SM)

ethambutol (EMB)

levofloxacin (LVFX)

amikacin (AMK) and capreomycin (CMP) in spinal tuberculosis. Methods The new DNA microarray was designed to test the resistance-determining regions in rrs and rpsL (SM)

embB (EMB)

gyrA and gyrB (LVFX)

and rrs (AMK and CMP). A set of 111 drug-resistant Mycobacterium tuberculosis strains

and 26 drug sensitive Mycobacterium tuberculosis strains with full clinical data and sensitivity test results were tested by the new DNA microarray and by DNA sequencing after inactivation

nucleic acid extraction

PCR amplification

chip hybridization

washing and scanning interpretation. The sensitivity and specificity were evaluated. Results The average detection time was 20.1±1.2 h (ranged from 18 to 23 h). The sensitivity of the MTBDR test was 90.36%

61.90%

94.59%

66.00% and 65.52% for SM/EMB/LVFX/AMK/CPM respectively

and their specificity was 70.37%

58.11%

58.00%

91.95% and 80.56%

respectively. All 26 drug sensitive Mycobacterium tuberculosis strains were identified as wild type

and the specificity of these wild type strains was 100% for all 5 drugs. Conclusion This new DNA microarray is a rapid approach of good biosafety and high sensitivity and specificity in resistance test of first and second line MTB drug for the isolated Mycobacterium tuberculosis strains

and is satisfying in clinical practice for rapid diagnosis of drug-resistant Mycobacterium tuberculosis strains.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Drug susceptibility-guided individual anti-tuberculous chemotherapy for spinal tuberculosis: report of 46 cases

Investigation on expression pattern of multidrug resistance-associated gene in human small cell lung cancer cell lines SH77/CDDP using gene chip technique

Preparation of nanosized hypoxia-inducible factor 1α inhibitor and its application in reversing chemoresistance in colorectal cancer cells

Silencing high mobility group protein B1 inhibits malignant biological behavior of glioblastoma cells

MiRNA-200b reverses drug resistance of hepatocellular carcinoma HepG2 cells to sorafenib and its underlying mechanism

Related Author

许建中

张泽华

万东勇

周强

廖传玉

赵小莉

何清义

代飞

Related Institution

Department of Gastroenterology， Second Affiliated Hospital， Army Medical University （Third Military Medical University）

⁰